Echocardiography Clinical Trial
— SepsistrainOfficial title:
Strain Echocardiography During Septic Shock : an Observational Pilot Study
Verified date | May 2019 |
Source | Centre Hospitalier Universitaire de Nimes |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The mortality of septic shock remains high nowadays despite a trend toward improvement.Septic
cardiomyopathy has been reported in most experimental models of sepsis shock. Its
relationship with mortality is unclear. A decrease in mortality have been reported in
patients with decreased left ventricular ejection fraction (LVEF), but a recent meta-analysis
did not support such results. In fact, it appears that high LVEF are linked to profound
vasoplegia which is associated to bad outcome.
In the other hand, alterations of Strain echocardiography, a new method allowing a more
sensitive evaluation of heart function, have been associated with a worse outcome in sepsis
patients. Only few studies have examined echocardiographic strain during sepsis shock in
human, and its natural history was only described in pigs. Moreover, the right ventricular
strain was reported only by Orde et al whereas the evolution of strain during fluid infusion
have never been studied. The aim of the present study is to describe the natural history of
echocardiographic strain during sepsis shock and to determine its prognosis value.
Status | Completed |
Enrollment | 50 |
Est. completion date | April 30, 2018 |
Est. primary completion date | March 30, 2018 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Septic shock (suspected or proven infection and norepinephrine = 0,25µg/kg/min) - Inclusion within the first 24h of septic shock Exclusion Criteria: - Patient < 18 year of age - Pregnant women - History of myocardial infarction, valvular disease, atrial fibrillation |
Country | Name | City | State |
---|---|---|---|
France | Intensive care unit CHU Nimes | Nîmes |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Global peak systolic longitudinal strain assessed by echocardiography. Global peak systolic longitudinal strain | up to 90 days | ||
Secondary | ICU mortality | On the day of patient discharge from the ICU | up to 90 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03592693 -
Vitamin C, Hydrocortisone and Thiamine for Septic Shock
|
Phase 2 | |
Terminated |
NCT01639664 -
COMPACT 2 - COMbining Plasma-filtration and Adsorption Clinical Trial 2
|
N/A | |
Withdrawn |
NCT01601938 -
Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients
|
Phase 2 | |
Recruiting |
NCT00335907 -
Protocol-driven Hemodynamic Support for Patients With Septic Shock
|
N/A | |
Completed |
NCT00000574 -
Ibuprofen in Sepsis Study
|
Phase 3 | |
Recruiting |
NCT04910841 -
Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medicine
|
N/A | |
Active, not recruiting |
NCT04079829 -
Postoperative Respiratory Abnormalities
|
||
Recruiting |
NCT04569942 -
Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis
|
Phase 3 | |
Recruiting |
NCT04934943 -
"Mini Fluid Challenge Assessment: a Comparison Among Three Hemodynamic Tools"
|
||
Completed |
NCT01310790 -
Strategy of Early Improvement of Tissue Oxygenation Decrease the Mortality of Severe Sepsis and Septic Shock
|
Phase 4 | |
Completed |
NCT00241228 -
Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)
|
N/A | |
Completed |
NCT00046072 -
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
|
Phase 2 | |
Withdrawn |
NCT03122678 -
Thiamine Supplementation in Patients With Septic Shock
|
Phase 1 | |
Recruiting |
NCT06155812 -
Multimodal Vasopressor Strategy in Septic Shock
|
Phase 2/Phase 3 | |
Completed |
NCT04178148 -
Personalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic Shock
|
N/A | |
Completed |
NCT01453270 -
Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis Trial
|
N/A | |
Completed |
NCT04576819 -
Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
|
||
Active, not recruiting |
NCT04055909 -
Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
|
Phase 2 | |
Suspended |
NCT03193164 -
Neuromuscular Electrical Stimulation and Septic Shock
|
N/A | |
Completed |
NCT04647552 -
Effects of Hydrocortison Treatment on Angiotensin II and Angiotensin II Receptors in Patients With Septic Shock
|